Melissa Pugliano-Mauro

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Melissa Pugliano-Mauro sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials 3 currently recruiting early-phase tilt upper quartile by trial count

Melissa Pugliano-Mauro: 3 sponsored US clinical trials, 3 recruiting.

Melissa Pugliano-Mauro sponsors 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Scar, with 2 trials.

Upper-quartile sponsor footprint

Melissa Pugliano-Mauro sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

3 total, page 1 of 1

RECRUITING NA

Impact of Suture Type on Pigment Disturbances in Patients of Skin of Color

NCT05408117
RECRUITING Early Phase 1

Zinc Oxide Versus Petrolatum Following Skin Surgery

NCT03561376
RECRUITING Phase 1

Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC

NCT03370406

Phase Distribution

PhaseTrial count
Phase 1 2

Therapeutic Areas

Scar 2
Carcinoma, Squamous Cell 1
Hypertrophic Scar 1
Surgical Site Infection 1
Surgical Wound 1
Surgery--Complications 1
Surgical Incision 1

What is open in the Melissa Pugliano-Mauro pipeline

3 recruiting of 3 indexed (100% open).

Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).

Top condition: Scar (2 trials), 6 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Melissa Pugliano-Mauro: open-pipeline peers nationwide

Peers matched on 3 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Melissa Pugliano-Mauro sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1.522.533.544.5 0%50%100%150% Total trials Recruiting share Melissa Pugliano-Mauro10xBio22nd Century GroupAA SecordAAADRS Clinical Research CenterAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
Melissa Pugliano-Mauro sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Melissa Pugliano-Mauro sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Melissa Pugliano-Mauro page

3 registered trials is a research-attention snapshot, not an endorsement of Melissa Pugliano-Mauro or any single study.

  • 3 of Melissa Pugliano-Mauro's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Scar is the condition Melissa Pugliano-Mauro studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Scar trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Melissa Pugliano-Mauro pipeline card: 3 registered trials from official public datasets.Report a data error.